Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Functional characterization of NPM1-TYK2 fusion oncogene.
Kuravi S, Baker RW, Mushtaq MU, Saadi I, Lin TL, Vivian CJ, Valluripalli A, Abhyankar S, Ganguly S, Cui W, Elenitoba-Johnson KSJ, Welch DR, Jensen RA, Saunthararajah Y, McGuirk JP, Balusu R. Kuravi S, et al. Among authors: balusu r. NPJ Precis Oncol. 2022 Jan 18;6(1):3. doi: 10.1038/s41698-021-00246-4. NPJ Precis Oncol. 2022. PMID: 35042970 Free PMC article.
Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma.
Subbiah V, Kuravi S, Ganguly S, Welch DR, Vivian CJ, Mushtaq MU, Hegde A, Iyer S, Behrang A, Ali SM, Madison RW, Venstrom JM, Jensen RA, McGuirk JP, Amin HM, Balusu R. Subbiah V, et al. Among authors: balusu r. ESMO Open. 2021 Aug;6(4):100172. doi: 10.1016/j.esmoop.2021.100172. Epub 2021 Jul 7. ESMO Open. 2021. PMID: 34242968 Free PMC article.
When the good go bad: Mutant NPM1 in acute myeloid leukemia.
Kunchala P, Kuravi S, Jensen R, McGuirk J, Balusu R. Kunchala P, et al. Among authors: balusu r. Blood Rev. 2018 May;32(3):167-183. doi: 10.1016/j.blre.2017.11.001. Epub 2017 Nov 4. Blood Rev. 2018. PMID: 29157973 Review.
Targeted Therapy for EBV-Associated B-cell Neoplasms.
Ganguly S, Kuravi S, Alleboina S, Mudduluru G, Jensen RA, McGuirk JP, Balusu R. Ganguly S, et al. Among authors: balusu r. Mol Cancer Res. 2019 Apr;17(4):839-844. doi: 10.1158/1541-7786.MCR-18-0924. Epub 2018 Nov 28. Mol Cancer Res. 2019. PMID: 30487243 Free PMC article.
Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
Mushtaq MU, Shahzad M, Chaudhary SG, Luder M, Ahmed N, Abdelhakim H, Bansal R, Balusu R, DeJarnette S, Divine C, Kribs R, Shune L, Singh AK, Ganguly S, Abhyankar SH, McGuirk JP. Mushtaq MU, et al. Among authors: balusu r. Transplant Cell Ther. 2021 Sep;27(9):796.e1-796.e7. doi: 10.1016/j.jtct.2021.07.005. Epub 2021 Jul 10. Transplant Cell Ther. 2021. PMID: 34256172 Free PMC article.
Impact of natural killer cells on outcomes after allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
Mushtaq MU, Shahzad M, Shah AY, Chaudhary SG, Zafar MU, Anwar I, Neupane K, Khalid A, Ahmed N, Bansal R, Balusu R, Singh AK, Abhyankar SH, Callander NS, Hematti P, McGuirk JP. Mushtaq MU, et al. Among authors: balusu r. Front Immunol. 2022 Oct 3;13:1005031. doi: 10.3389/fimmu.2022.1005031. eCollection 2022. Front Immunol. 2022. PMID: 36263054 Free PMC article.
Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Shahzad M, Siddiqui RS, Anwar I, Chaudhary SG, Ali T, Naseem M, Ahmed TF, Ahmed Z, Khurana S, Ahmed N, Balusu R, Singh AK, Hematti P, Callander NS, Abhyankar SH, McGuirk JP, Mushtaq MU. Shahzad M, et al. Among authors: balusu r. Transplant Cell Ther. 2021 Oct;27(10):877.e1-877.e8. doi: 10.1016/j.jtct.2021.07.012. Epub 2021 Jul 18. Transplant Cell Ther. 2021. PMID: 34284148 Free article.
64 results